title: Visceral leishmaniasis in a patient with systemic juvenile arthritis treated by IL-1RA agonist (Anakinra).
authors.forename: I
authors.initials: I
authors.lastname: Koné-Paut
authors.forename: K
authors.initials: K
authors.lastname: Retornaz
authors.forename: J M
authors.initials: JM
authors.lastname: Garnier
authors.forename: B
authors.initials: B
authors.lastname: Bader-Meunier
mesh_terms: D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D001171:Arthritis, Juvenile / Q000188:drug therapy*; D002648:Child; D005260:Female; D006801:Humans; D016867:Immunocompromised Host / Q000187:drug effects*; D053590:Interleukin 1 Receptor Antagonist Protein / Q000009:adverse effects*; D007898:Leishmaniasis, Visceral / Q000276:immunology*
chemical_list: D000893:Anti-Inflammatory Agents; D053590:Interleukin 1 Receptor Antagonist Protein